Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Versatile Evaporator for Lab & Batch Processing Tasks
Friday, October 17, 2014
New Rocket Synergy series offers automated evaporation of a wide range of sample formats and sizes.

Manifold Ensures Safe Secure & Efficient Reaction Cooling
Friday, October 17, 2014
Asynt’s DrySyn water manifold will keep the condenser tubing safe, secure and tidy.

Oerlikon Leybold Vacuum Moves Offices in the Netherlands
Thursday, October 16, 2014
New premises offer growth opportunities.

Anyone for Coffee?
Saturday, October 11, 2014
Heidolph rotary evaporator features in C4 Gadget Man show.

Micro Droplet Systems from Dolomite
Saturday, October 04, 2014
Provide automatic, seamless production of monodispersed droplets.

New Line of XPE Balances from Mettler Toledo
Tuesday, September 30, 2014
The new XPE balances deliver accurate, compliant results and provide users with a high level of process security, suitable for even the strictest regulations.

Gas Bubblers Ensure Maintenance of Inert Reaction Atmospheres
Wednesday, September 24, 2014
New range of gas bubblers from Asynt provide a one-way valve.

Bringing Photochemistry to the Bench with Vapourtec Innovation
Friday, September 19, 2014
easy-Photochem - A safe, easy-to-use, compact and affordable package.

New Application Note for TAP’s ambr15 Micro Bioreactors
Friday, September 12, 2014
Provides tips on how to maximize data collection with minimum sample volume and smart sampling regimes.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 917
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv